Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-6613

ABSTRACT: Microarray analysis of blood of individuals with early Parkinson's disease

DISEASE(S): Essential Tremor,Progressive Supranuclear Palsy,Alzheimers Disease,Corticobasal Degeneration,Multiple System Atrophy,Parkinson's Disease,Normal

PROVIDER: E-GEOD-6613 | ExpressionAtlas | 2017-09-15

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-6613-analysis-methods.tsv	Tabular
	E-GEOD-6613-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-6613-configuration.xml	Xml
	E-GEOD-6613-percentile-ranks.tsv	Tabular
	E-GEOD-6613.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 54

Similar Datasets

Transcription profiling of human patients with Parkinsons disease (50), 33 patients with neurodegenerative diseases other than PD, and 23 healthy controls

Project description:Parkinson's disease (PD) progresses relentlessly and affects five million people worldwide. Laboratory tests for PD are critically needed for developing treatments designed to slow or prevent progression of the disease. We performed a transcriptome-wide scan in 105 individuals to interrogate the molecular processes perturbed in cellular blood of patients with early-stage PD. The molecular marker here identified is strongly associated with risk of PD in 66 samples of the training set (third tertile cross-validated odds ratio of 5.7 {P for trend 0.005}). It is further validated in 39 independent test samples (third tertile odds ratio of 5.1 {P for trend 0.04}). The genes differentially expressed in patients with PD, or Alzheimer's or progressive supranuclear palsy offer unique insights into disease-linked processes detectable in peripheral blood. Combining gene expression scans in blood and linked clinical data will facilitate the rapid characterization of candidate biomarkers as demonstrated here with respect to PD. Experiment Overall Design: Whole blood expression data from 50 patients with Parkinson's disease, 33 with neurodegenerative diseases other than PD, and 23 healthy controls.

2008-11-22 | E-GEOD-6613 | biostudies-arrayexpress

Project description:Early-onset Parkinson's disease

| PRJNA886997 | ENA

Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms

Project description:Detailed analysis of disease-affected tissue provides insight into molecular mechanisms contributing to pathogenesis. Substantia nigra, striatum and cortex are functionally connected with increasing degrees of alpha-synuclein pathology in Parkinson's disease. Functional and causal pathway analysis of gene expression and proteomic alterations in these three regions revealed pathways that correlated with deposition of alpha-synuclein. Microarray and RNAseq experiments revealed previously unidentified causal changes related to oligodendrocyte function and synaptic vesicle release and other changes were reflected across all brain regions. Importantly a subset of these changes were replicated in Parkinson's disease blood. Proteomic assessment revealed alterations in mitochondria and vesicular transport proteins that preceded gene gene expression changes indicating defects in translation and/or protein turnover. Our combined approach of proteomics, RNAseq and microarray analyses provides a comprehensive view of the molecular changes that accompany alpha-synculein pathology in Parkinson's disease, and may be instrumental in understanding and diagnosing Parkinson's disease progression.

2014-09-01 | GSE54282 | GEO

Homo sapiens

Project description:Association between alpha-synuclein blood transcripts and early Parkinson's disease

| PRJNA246570 | ENA

E-GEOD-72267

Project description:Microarray analysis of blood of 40 sporadic Parkinson's disease patients and 20 healthy controls

2018-04-05 | E-GEOD-72267 | ExpressionAtlas

Parkinson's Families Project

Project description:SNP array data of 698 individuals with early onset and/or familial Parkinson's disease.

| EGAS00001007906 | EGA

Epigenome analysis of Parkinson's disease and control samples from the Systema Genomics Parkinson's disease (SGPD) consortium

Project description:Genome wide DNA methylation association analysis of Parkinson's disease and control samples. The Illumina Infinium 450k Human DNA methylation Beadchip was used to obtain DNA methylation profiles across approximately 450,000 CpGs in blood samples. Samples included 1001 Parkinson's disease cases and 973 controls.

2020-02-17 | GSE145361 | GEO

System-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms

2014-09-01 | E-GEOD-54282 | biostudies-arrayexpress

Rehabilitative Impact of Exercise Training on Human Skeletal Muscle Transcriptional Programs in Parkinson’s Disease

Project description:We performed transcriptional profiling to test the hypotheses that a) type I myofiber grouping severity in Parkinson's disease skeletal muscle is linked to distinct gene expression networks and b) high-intensity resistance exercise rehabilitation training influences the skeletal muscle transcriptome in individuals with Parkinson's disease.

2020-05-20 | GSE140089 | GEO

Homo sapiens

Project description:Parkinson's disease vs. controls, whole blood

| PRJNA98879 | ENA